TY  - GEN
AU  - Lockwood,C M
AU  - Hale,G
AU  - Waldman,H
AU  - Jayne,D R W
TI  - Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H
SN  - 1462-0324
PY  - 2004///0123
KW  - Adolescent
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antirheumatic Agents
KW  - Behcet Syndrome
KW  - drug therapy
KW  - CD4 Lymphocyte Count
KW  - Disease-Free Survival
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunosuppressive Agents
KW  - administration & dosage
KW  - Lymphocyte Depletion
KW  - methods
KW  - Male
KW  - Middle Aged
KW  - Prednisolone
KW  - Remission Induction
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1093/rheumatology/keg424
ER  -